Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepke

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
The European Respiratory Journal|July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studiesS Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
Nature Communications|November 26, 2022
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|September 30, 2021
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Colin Church, Lars Harbaum, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2022
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial HypertensionRowena J Jones, Eckart M D D De Bie, Emily Groves, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
Circulation|October 4, 2017
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Marta Bleda, Matthias Haimel, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
The European Respiratory Journal|July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studiesS Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
Nature Communications|November 26, 2022
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|September 30, 2021
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Colin Church, Lars Harbaum, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2022
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial HypertensionRowena J Jones, Eckart M D D De Bie, Emily Groves, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
Circulation|October 4, 2017
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Marta Bleda, Matthias Haimel, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.
Pageof 32